<SEC-DOCUMENT>0001564590-20-020177.txt : 20200430
<SEC-HEADER>0001564590-20-020177.hdr.sgml : 20200430
<ACCEPTANCE-DATETIME>20200430161008
ACCESSION NUMBER:		0001564590-20-020177
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20200430
DATE AS OF CHANGE:		20200430
EFFECTIVENESS DATE:		20200430

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			resTORbio, Inc.
		CENTRAL INDEX KEY:			0001720580
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				813305277
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38359
		FILM NUMBER:		20835735

	BUSINESS ADDRESS:	
		STREET 1:		500 BOYLSTON STREET
		STREET 2:		12TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		617-482-2333

	MAIL ADDRESS:	
		STREET 1:		500 BOYLSTON STREET
		STREET 2:		12TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>torc-defa14a_20200603.htm
<DESCRIPTION>DEFA14A
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
torc-defa14a_20200603.htm
</title>
</head>
<!-- NG Converter v5.0.2.38 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;border-top:Double 2.25pt;padding-top:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;"><a name="_Hlk38528299"></a>&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES<br />SECURITIES AND EXCHANGE COMMISSION</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549</p>
<p style="text-align:center;border-top:none 0pt;padding-top:0pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:38.64%;margin-right:38.64%;text-indent:0%;font-size:8pt;">&nbsp;</p>
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SCHEDULE 14A</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Rule 14a-101)</p>
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Information Required in Proxy Statement<br />Schedule 14A Information</p>
<p style="margin-bottom:0pt;margin-top:8pt;text-align:center;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Proxy Statement Pursuant to Section 14(a) of the<br />Securities Exchange Act of 1934</p>
<p style="text-align:center;border-top:none 0pt;padding-top:0pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:38.64%;margin-right:38.64%;text-indent:0%;font-size:10pt;font-family:Times New Roman;">&nbsp;</p>
<p style="border-top:none 0pt;padding-top:0pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  style="width:31.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Filed by the Registrant <font style="font-family:Segoe UI Symbol;">&#9746;</font></p></td>
<td valign="top"  style="width:35.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Filed by a Party other than the Registrant <font style="font-family:Segoe UI Symbol;">&#9744;</font></p></td>
<td valign="top"  style="width:33.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</font></p></td>
<td valign="top">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Preliminary Proxy Statement</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</font></p></td>
<td valign="top">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</font></p></td>
<td valign="top">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Definitive Proxy Statement</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9746;</font></p></td>
<td valign="top">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Definitive Additional Materials</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</font></p></td>
<td valign="top">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Soliciting Material Pursuant to &#167;240.14a-12</p></td></tr></table></div>
<p style="text-align:center;margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:22pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">resTORbio, Inc.</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Name of Registrant as Specified in its Charter)</p>
<p style="margin-bottom:0pt;margin-top:8pt;text-align:center;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</p>
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payment of Filing Fee (Check the appropriate box):</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9746;</font></p></td>
<td valign="top">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">No fee required.</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</font></p></td>
<td valign="top">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Title of each class of securities to which transaction applies:</p></td></tr></table></div>
<p style="margin-top:0pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-left:8.82%;text-indent:-2.08%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2)</font></p></td>
<td valign="top">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Aggregate number of securities to which transaction applies:</p></td></tr></table></div>
<p style="margin-top:0pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-left:8.82%;text-indent:-2.08%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3)</font></p></td>
<td valign="top">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):</p></td></tr></table></div>
<p style="margin-top:0pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-left:8.82%;text-indent:-2.08%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4)</font></p></td>
<td valign="top">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Proposed maximum aggregate value of transaction:</p></td></tr></table></div>
<p style="margin-top:0pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-left:8.82%;text-indent:-2.08%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5)</font></p></td>
<td valign="top">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Total fee paid:</p></td></tr></table></div>
<p style="margin-top:0pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-left:8.82%;text-indent:-2.08%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</font></p></td>
<td valign="top">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Fee paid previously with preliminary materials.</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</font></p></td>
<td valign="top">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</font></p></td>
<td valign="top">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Amount Previously Paid:</p></td></tr></table></div>
<p style="border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:6.44%;text-indent:0%;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2)</font></p></td>
<td valign="top">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Form, Schedule or Registration Statement No.:</p></td></tr></table></div>
<p style="margin-top:0pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-left:8.82%;text-indent:-2.08%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3)</font></p></td>
<td valign="top">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Filing Party:</p></td></tr></table></div>
<p style="margin-top:0pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-left:8.82%;text-indent:-2.08%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.22%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4)</font></p></td>
<td valign="top">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Date Filed:</p></td></tr></table></div>
<p style="margin-top:0pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-left:8.82%;text-indent:-2.08%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:9pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:9pt;">&nbsp;</p>
<p style="margin-top:3pt;text-align:center;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SUPPLEMENT TO</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">NOTICE OF THE 2020 ANNUAL MEETING OF SHAREHOLDERS AND PROXY STATEMENT</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">DATED MARCH 27, 2020</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FOR THE ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 6, 2020</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This supplement (the &#8220;Supplement&#8221;) provides updated information with respect to the 2020 Annual Meeting of Shareholders (the &#8220;Annual Meeting&#8221;) of resTORbio, Inc. (&#8220;resTORbio&#8221;) previously scheduled to be held on May 6, 2020, which will now be held on June 3, 2020. &#160;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 27, 2020, resTORbio commenced distributing to its shareholders a Notice of the 2020 Annual Meeting of Shareholders and Definitive Proxy Statement (the &#8220;Notice and Proxy Statement&#8221;) for the Annual Meeting previously to be held on May 6, 2020. This Supplement, which describes a change in (i) the location of the Annual Meeting from an in-person to a virtual-only meeting and (ii) the date of the annual meeting from May 6, 2020 to June 3, 2020, should be read in conjunction with the Notice and Proxy Statement.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9.5pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Change in Annual Meeting Location and Date; Virtual-Only Meeting to be Held</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On April 30, 2020, resTORbio issued a press release announcing that, resTORbio will change the date of its Annual Meeting to June 3, 2020 at 1:00 p.m. ET and will host the Annual Meeting virtually due to the public health impact of the coronavirus pandemic and to prioritize the health and well-being of meeting participants.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Annual Meeting will be held in a virtual format only at 1:00 p.m. (ET) on Wednesday, June 3, 2020. Shareholders will not be able to attend the Annual Meeting in person.</p>
<p style="margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shareholders of record may vote by internet at www.proxyvote.com, by telephone using a touch-tone telephone at 1-800-690-6903 or by marking, signing and dating the proxy card and returning it in the postage-paid envelope provided to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717 by 11:59 p.m. ET on June 2, 2020. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As described in the Notice and Proxy Statement, shareholders at the close of business on the record date, March 16, 2020, are entitled to attend the Annual Meeting. Shareholders at the close of business on the record date, March 16, 2020, are entitled to attend the 2020 annual meeting. To attend and participate in the Annual Meeting, shareholders must register in advance at http://viewproxy.com/restorbio/2020 (the &#8220;Meeting Registration Website&#8221;) prior to the deadline of 11:59 p.m. ET on June 1, 2020. Upon completing registration, eligible participants will receive further instructions via email, including unique links that will allow such eligible participants to access the meeting. Eligible participants who have difficulty accessing the virtual meeting or the Meeting Registration Website may call the technical support number provided.  </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Please note that the proxy card and voting instruction form included with previously-distributed proxy materials will not be updated to reflect the change from an in-person meeting to a virtual-only meeting and may be used to vote shares in connection with the annual meeting. Whether or not shareholders plan to attend the virtual-only annual meeting, resTORbio urges shareholders to vote and submit their proxies in advance of the meeting by one of the methods described in the proxy materials.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By Order of the Board of Directors,</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:5.5pt;">&nbsp;</p>
<p style="margin-top:4pt;margin-bottom:0pt;text-indent:0%;letter-spacing:-2.5pt;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">/</font><font style="text-decoration:underline;letter-spacing:0.2pt;"> </font><font style="text-decoration:underline;">s/ Chen Shor</font><font style="text-decoration:underline;margin-left:36pt;"></font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">President, Chief Executive Officer and Secretary</p>
<p style="margin-top:5pt;margin-bottom:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">April 30, 2020</p>
<p style="border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, on April 30, 2020, the Company issued the following press release related to the date change and change to a virtual format.</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.44%;margin-right:5.72%;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU2"></a><img src="gbsrdf4vbeub000001.jpg" title="" alt="" style="width:259px;height:63px;"><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:9.5pt;">&nbsp;</p>
<p style="margin-top:4pt;margin-bottom:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">FOR IMMEDIATE RELEASE</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:14.5pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">resTORbio to Host its 2020 Annual Shareholder Meeting Virtually on June 3, 2020</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:9.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Boston, MA, April 30, 2020 <font style="font-weight:normal;">- resTORbio, Inc. (Nasdaq: TORC) today announced that due to the public health impact of the coronavirus pandemic and to prioritize the health and well-being of its employees, stockholders, and other meeting participants, the company has changed the date and format of its 2020 Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;). The Annual Meeting will now be held at 1:00 p.m. (ET) on Wednesday, June 3, 2020 by means of a virtual meeting format only instead of the date and location previously disclosed in resTORbio&#8217;s proxy materials filed with the Securities and Exchange Commission on March 27, 2020. Shareholders will not be able to attend the 2020 annual meeting in person.</font></p>
<p style="margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shareholders at the close of business on the record date, March 16, 2020, are entitled to attend the 2020 annual meeting. To attend and participate in the Annual Meeting, shareholders must register in advance at http://viewproxy.com/restorbio/2020 (the &#8220;Meeting Registration Website&#8221;) prior to the deadline of 11:59 p.m. ET on June 1, 2020. Upon completing registration, eligible participants will receive further instructions via email, including unique links that will allow such eligible participants to access the meeting. Eligible participants who have difficulty accessing the virtual meeting or the Meeting Registration Website may call the technical support number provided.  </p>
<p style="margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shareholders of record may vote by internet at www.proxyvote.com, by telephone using a touch-tone telephone at 1-800-690-6903 or by marking, signing and dating the proxy card and returning it in the postage-paid envelope provided to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717 by 11:59 p.m. ET on June 2, 2020. </p>
<p style="margin-top:9pt;margin-bottom:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Please note that the proxy card and voting instruction form included with previously distributed proxy materials will not be updated to reflect the change from an in-person meeting to a virtual-only meeting and may be used to vote shares in connection with the annual meeting. Whether or not shareholders plan to attend the virtual-only annual meeting, resTORbio urges shareholders to vote and submit their proxies in advance of the meeting by one of the methods described in the proxy materials. </p>
<p style="margin-top:9pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:9.5pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">About resTORbio</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">resTORbio, Inc. is a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to treat aging-related diseases. resTORbio&#8217;s lead program selectively inhibits TORC1, an evolutionarily conserved pathway that contributes to the decline in function of aging organ systems, including neurologic function. Learn more about resTORbio, Inc. at&#160;www.resTORbio.com.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Investor Contact<font style="font-weight:normal;"><br />Janhavi Mohite<br />Stern Investor Relations, Inc.<br />212-362-1200<br /></font><font style="text-decoration:underline;font-weight:normal;">janhavi.mohite@sternir.com</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:9pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Media Contact<font style="font-weight:normal;"><br />Lauren Arnold<br />MacDougall<br />617-694-5387<br /></font><font style="text-decoration:underline;font-weight:normal;">larnold@macbiocom.com</font></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-top:4pt;text-align:center;margin-bottom:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:bold;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>gbsrdf4vbeub000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gbsrdf4vbeub000001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !  00# 2(  A$! Q$!_\0
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M %JT^I5_Y3+^U,+_ #'?TR66.)&DD=411DLQP!69I6MK?Z&-2N L"?,6YR%
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M_P Z]O'W1]*[LPK3IN/*['G93AZ553]HKV/._%31:/I=MH%K*S+DR2;NN,Y
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MCU,*$_\ ?(KF?B+,%T"* 'YYIU 'K@'_ .M74649BL;>,]4B53^ H GHHHH
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+[BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
